Atrial natriuretic peptide involvement in human platelet aggregability in vitro.
Atrial natriuretic peptide (ANP) counteracts the destabilization and aggregation of platelets which is induced by vasopressin, angiotensin, and adrenaline.
Pella
R
R
Institut für Klinische Biochemie, Universität Bonn.
von Ruecker
A
A
Bidlingmaier
F
F
D000804:Angiotensin II / Q000494:pharmacology; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D014667:Vasopressins / Q000494:pharmacology
D014667:Vasopressins; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D004837:Epinephrine